Page 14 - மருந்தியல் ஆபத்து மதிப்பீடு குழு News Today : Breaking News, Live Updates & Top Stories | Vimarsana
EMA Finds Link Between Johnson & Johnson Vaccine and Blood Clots - New Delhi Times - India s Only International Newspaper
newdelhitimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newdelhitimes.com Daily Mail and Mail on Sunday newspapers.
Johnson & Johnson to resume Covid-19 vaccine roll-out in Europe after EMA review
pharmaceutical-business-review.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmaceutical-business-review.com Daily Mail and Mail on Sunday newspapers.
EMA calls for warning of very rare side-effects on J&J vaccine
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.
Johnson & Johnson (NYSE:JNJ), Astrazeneca PLC (NYSE:AZN) - Johnson & Johnson Set To Resume COVID-19 Vaccine Rollout In Europe — With A Warning On The Label
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
Johnson & Johnson to resume deliveries of Covid-19 vaccine to EU European regulator finds benefits of one-shot vaccine outweigh risks of rare blood clots
about 10 hours ago Updated: about 5 hours ago
Pharmaceutical company Johnson & Johnson is to resume deliveries of its one-shot Covid-19 vaccine to the European Union after the European Medicines Agency (EMA) confirmed its benefits outweighed the risks of blood clots as a very rare side effect.
The vaccine leaflet is to be updated to include information on the diagnosis and treatment after the EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) reviewed eight reported cases of unusual blood clots combined with low platelets among over seven million people who received the jab in the United States.